Brief: XSpray Pharma Gets Additional Product Patent In The US
Dec 4 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* ADDITIONAL PRODUCT PATENT IN THE UNITED STATES FOR
HYNAP-DASA
* NEW PATENT WILL EXPIRE JANUARY 11, 2033
Source text for Eikon: ID:nWkr7f2lW0
Further company coverage: XSPRAY.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))